HOME >> MEDICINE >> NEWS
GlaxoSmithKline Drug Discovery and Development Award 2002

Six HIV and AIDS researchers will split $500,000 as this year's recipients of the GlaxoSmithKline (GSK) Drug Discovery and Development Award. The unrestricted research award program is funded by GSK to support independent, innovative and novel research in the development of HIV/AIDS therapeutics.

An Expert Review Board, composed of researchers who are leaders in the field of HIV/AIDS, independently judged and selected the award recipients. John A. Bartlett, M.D., professor of medicine at Duke University Medical Center; David D. Ho, M.D., professor at Rockefeller University and scientific director at Aaron Diamond AIDS Research Center; and Michael Saag, M.D., associate professor of medicine and director of the AIDS Outpatient Clinic at the University of Alabama at Birmingham, served on the board this year.

Recipients of the awards are Irwin Chaiken, Ph.D., University of Pennsylvania, Philadelphia, for his work studying the interactions between proteins that allow HIV to recognize and enter a host cell, research that potentially will lead to drugs that prevent the virus-cell fusion process; Nouri Neamati, Ph.D., University of Southern California School of Pharmacy, Los Angeles, for work in identifying the drug-binding site on HIV integrase, which should lead to development of second- and third-generation drugs that inhibit that enzyme; Alan C. Sartorelli, Ph.D., Yale University School of Medicine, New Haven, Conn., for his research on making certain enzyme inhibitors work more effectively; Nan-Sook Lee, Ph.D., Beckman Institute of the City of Hope, Duarte, Calif., for her research using gene therapy as a potential HIV/AIDS treatment; Elias Lolis, Ph.D., Yale University School of Medicine, for his work in attempting to solve likely side effects of some of the experimental entry inhibitor drugs; and Min Lu, Ph.D., Weill Medical College of Cornell University, New York, N.Y., for his research of a drug developed for herpes that may eventually be used for
'"/>

Contact: Elaine Salewske
esalewske@pcipr.com
312-558-1770
Public Communications Inc.
1-Oct-2002


Page: 1 2 3 4 5

Related medicine news :

1. TB Alliance announces new drug discovery program with GlaxoSmithKline
2. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
3. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
4. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003
6. GlaxoSmithKline Drug Discovery and Development Award 2002
7. Discovery of pathway in learning impairment caused by liver disease may lead to drug treatment
8. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
9. Discovery of the oldest remains of a woman who died in childbirth
10. Discovery sheds light on how cancer cells grow and divide
11. Discovery changes ideas about damage from strokes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... ... 2018 , ... Becker's Healthcare named the following institutions to ... programs." , The hospitals named on this list are national leaders in cardiovascular ... pioneered groundbreaking procedures and remain on the forefront of heart care today. Others ...
(Date:12/10/2018)... ... December 10, 2018 , ... The most active U.S. markets ... once again host the CWCBExpo (Cannabis World Congress) leading B2B trade shows and conferences. ... York, May 29-June 1, 2019, Jacob K. Javits Convention Center, New York, NY , ...
(Date:12/8/2018)... , ... December 07, 2018 , ... ... Community Service for its annual tradition of supporting non-profit organizations through fun, creative ... Garland employees helping raise more than $400,000 for charities in northeast Ohio and ...
(Date:12/8/2018)... ... 08, 2018 , ... The Human Animal Bond Research Institute ... parents, has become an official supporter of HABRI and its research on the ... of human-animal bond research, whiskerDocs is demonstrating its commitment to the human-animal bond ...
(Date:12/6/2018)... ... December 06, 2018 , ... We all know stress is ... solutions. M.D.-formulated Relaxium Calm is a dietary supplement developed to promote relaxation and ... extract of the ashwagandha root. Ashwagandha is a powerful herb that has been ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... , ... November 29, 2018 , ... More than 205,000 ... on the largest diabetes organizations to significantly increase funding for type 1 diabetes cure ... remained mostly flat since then. , An estimated two million Americans are affected by ...
(Date:11/28/2018)... ... November 28, 2018 , ... Satin Fine Foods, a manufacturer of cake ... Hudson Valley Honor Flight on Sept 28th, 2018 at the HVNY office in Walden ... to HVHF by Kevin O’Reilly, Founder and CEO of Satin Fine Foods, Inc. , ...
(Date:11/28/2018)... , ... November 28, 2018 , ... ... Corporation has been published and is available to view on the company’s ... crystal X-ray diffraction, published by Rigaku Oxford Diffraction , serving the X-ray ...
Breaking Medicine Technology:
Cached News: